55P EGFR variant allele frequency (VAF) impacts on metastatic NSCLC patients outcome during first-line osimertinib

Saved in:
Bibliographic Details
Published in:ESMO open 2023-10, Vol.8 (1), p.101865, Article 101865
Main Authors: Riva, S.T., Ogliari, F.R., Cangi, M.G., Bucci, G., Foggetti, G., Ferrara, R., Pecciarini, L., Oresti, S., Viganò, M.G., Damiano, G., Gandolfi, G., Guzzeloni, V., Valci, S., Ferrara, M., Nuccio, A., Venanzi, F.M., Pilotto, S., Bulotta, A., Milella, M., Reni, M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2023.101865